A study of Ibrutinib in combination with Rituximab versus Placebo in combination with Rituximab in treatment of patients with Follicular Lymphoma

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 4fe358ee04f07187a9d8dcb171ec426f35c1d953
First added on: Jan 16, 2026